Commonwealth Biotechnologies, Inc., was founded in 1992 to provide sophisticated research and development support services on a fee-for-service basis to the global biotechnology and pharmaceutical industry. Since 2004, CBI has pursued a strategy of acquiring or merging with complementary companies that extend its drug discovery capabilities and earnings potential.